These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 16408842
1. Molecular cloning of the gyrA gene and characterization of its mutation in clinical isolates of quinolone-resistant Edwardsiella tarda. Shin SB, Yoo MH, Jeong JB, Kim YM, Chung JK, Huh MD, Komisar JL, Jeong HD. Dis Aquat Organ; 2005 Nov 28; 67(3):259-66. PubMed ID: 16408842 [Abstract] [Full Text] [Related]
2. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda. Kim MS, Jun LJ, Shin SB, Park MA, Jung SH, Kim K, Moon KH, Jeong HD. J Microbiol Biotechnol; 2010 Dec 28; 20(12):1735-43. PubMed ID: 21193831 [Abstract] [Full Text] [Related]
5. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A. Vashist J, Vishvanath, Kapoor R, Kapil A, Yennamalli R, Subbarao N, Rajeswari MR. Indian J Biochem Biophys; 2009 Apr 28; 46(2):147-53. PubMed ID: 19517991 [Abstract] [Full Text] [Related]
6. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing. Beckmann L, Müller M, Luber P, Schrader C, Bartelt E, Klein G. J Appl Microbiol; 2004 Apr 28; 96(5):1040-7. PubMed ID: 15078520 [Abstract] [Full Text] [Related]
8. Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy. Matsuzaki J, Suzuki H, Tsugawa H, Nishizawa T, Hibi T. J Gastroenterol Hepatol; 2010 May 28; 25 Suppl 1():S7-10. PubMed ID: 20586870 [Abstract] [Full Text] [Related]
9. A nucleotide mutation associated with fluoroquinolone resistance observed in gyrA of in vitro obtained Rhodococcus equi mutants. Niwa H, Hobo S, Anzai T. Vet Microbiol; 2006 Jun 15; 115(1-3):264-8. PubMed ID: 16563665 [Abstract] [Full Text] [Related]
10. gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand. Pitaksajjakul P, Worakhunpiset S, Chaiprasert A, Boonyasopun J, Ramasoota P. Southeast Asian J Trop Med Public Health; 2011 Sep 15; 42(5):1163-7. PubMed ID: 22299442 [Abstract] [Full Text] [Related]
11. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Aubry A, Veziris N, Cambau E, Truffot-Pernot C, Jarlier V, Fisher LM. Antimicrob Agents Chemother; 2006 Jan 15; 50(1):104-12. PubMed ID: 16377674 [Abstract] [Full Text] [Related]
12. [Correlation between mutation of GyrA and ParC genes and quinolone resistance in Neisseria gonorrhoeae]. Xie P, Mi ZH, Li Q, Zhang J, Xiao CY. Zhonghua Nan Ke Xue; 2003 Jan 15; 9(4):275-8. PubMed ID: 12931370 [Abstract] [Full Text] [Related]
14. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations. McIver C, Hogan T, White P, Tapsall J. Pathology; 2004 Apr 15; 36(2):166-9. PubMed ID: 15203753 [Abstract] [Full Text] [Related]
15. Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies. Giles JA, Falconio J, Yuenger JD, Zenilman JM, Dan M, Bash MC. J Infect Dis; 2004 Jun 01; 189(11):2085-93. PubMed ID: 15143477 [Abstract] [Full Text] [Related]
16. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea. Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, Kim MN, Kim S, Kim YR, Lee CH, Lee K, Lee MA, Lee WG, Shin JH, Lee JN. Microb Drug Resist; 2011 Dec 01; 17(4):551-7. PubMed ID: 21830947 [Abstract] [Full Text] [Related]
17. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates. Walkty A, Boyd DA, Gravel D, Hutchinson J, McGeer A, Moore D, Simor A, Suh K, Taylor G, Miller M, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. Diagn Microbiol Infect Dis; 2010 Apr 01; 66(4):419-24. PubMed ID: 20226332 [Abstract] [Full Text] [Related]
18. Nucleotide sequence of the gyrA gene of Arcobacter species and characterization of human ciprofloxacin-resistant clinical isolates. Abdelbaqi K, Ménard A, Prouzet-Mauleon V, Bringaud F, Lehours P, Mégraud F. FEMS Immunol Med Microbiol; 2007 Apr 01; 49(3):337-45. PubMed ID: 17378897 [Abstract] [Full Text] [Related]
19. Molecular basis of quinolone resistance in Escherichia coli from wild birds. Jiménez Gómez PA, García de los Rios JE, Rojas Mendoza A, de Pedro Ramonet P, García Albiach R, Reche Sainz MP. Can J Vet Res; 2004 Jul 01; 68(3):229-31. PubMed ID: 15352551 [No Abstract] [Full Text] [Related]
20. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Madurga S, Sánchez-Céspedes J, Belda I, Vila J, Giralt E. Chembiochem; 2008 Sep 01; 9(13):2081-6. PubMed ID: 18677735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]